SCHEMBL21671818

SCHEMBL21671818

CN(C)Cc1cc2cc(N)ccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.53
▸ KEAP1 Q14145 1/20 0.53
▸ LOXL2 Q9Y4K0 4/20 0.45
▸ HRH4 Q9H3N8 1/20 0.38
▸ MAPT P10636 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ SIRT1 Q96EB6 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6252581 0.80 CYP2A6 (0.58) CYP2A6KEAP1LOXL2HRH4MAPT
SCHEMBL28220569 0.80 CYP2A6 (0.53) CYP2A6KEAP1LOXL2HRH4MAPT
SCHEMBL377753 0.79 CYP19A1 (0.44) CYP2A6LOXL2HRH4
SCHEMBL6252222 0.77 CYP2A6 (0.55) CYP2A6KEAP1LOXL2HRH4MAPT
SCHEMBL1429226 0.77 LOXL2 (0.67) LOXL2MAPTKDM4EMEN1KMT2A
SCHEMBL3578511 0.77 CYP2A6 (0.53) CYP2A6KEAP1LOXL2HRH4MAPT
SCHEMBL29750394 0.77 LOXL2 (0.58) LOXL2HRH4KDM4EHSD17B10
SCHEMBL4728647 0.77 LOXL2 (0.58) LOXL2HRH4KDM4EHSD17B10
SCHEMBL28083588 0.76 CYP2A6 (0.53) CYP2A6KEAP1LOXL2HRH4MAPT
SCHEMBL616859 0.76 CYP2A6 (0.44) CYP2A6LOXL2SIRT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 — — EP disclosed
Send feedback